The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9949998 Pharmaceutical composition, methods for treating and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

US Patent 9949998 Pharmaceutical composition, methods for treating and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 9949998 Pharmaceutical composition, methods for treating and uses thereof